Tenax Therapeutics, Inc. announced the appointment of Timothy Healey, MBA, as Chief Commercial Officer, effective May 4, 2026. Mr. Healey is a seasoned pharmaceutical executive who has developed and implemented innovative launch and commercialization models throughout his career. He most recently served as Chief Commercial Officer at Eversana Life Science Services, where he led the launch and commercialization efforts for a number of biopharmaceutical companies preparing for their initial commercial entry.
Prior to Eversana, Mr. Healey served as Senior Vice President, Commercial at Lantheus where he led a global staff spanning all commercial functions across the company?s product portfolio. Previously, he served as Vice President, US Virology at AbbVie and, before that, as Senior Vice President, Commercial at AMAG Pharmaceuticals. His commercial leadership experience has earned him some of the industry?s highest honors during his career, including being named Brandweek?s ?Marketer of the Year?
and leading a team that received Medical Marketing & Media?s ?Brand Team of the Year? award. Mr. Healey received a BS from Boston College and an MBA from Babson College.
